GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International, Inc. (FRA:HIY1) » Definitions » Price-to-Tangible-Book

Heartware International, (FRA:HIY1) Price-to-Tangible-Book : 13.05 (As of May. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Heartware International, Price-to-Tangible-Book?

As of today (2024-05-25), Heartware International,'s share price is €1.71. Heartware International,'s Tangible Book per Share of Jun. 2016 for the quarter that ended in Jun. 2016 was €0.13. Hence, Heartware International,'s Price to Tangible Book Ratio of today is 13.05.

The historical rank and industry rank for Heartware International,'s Price-to-Tangible-Book or its related term are showing as below:

FRA:HIY1' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.82   Med: 8.8   Max: 20.93
Current: 12.21

During the past 10 years, Heartware International,'s highest Price to Tangible Book Ratio was 20.93. The lowest was 4.82. And the median was 8.80.

FRA:HIY1's Price-to-Tangible-Book is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.7 vs FRA:HIY1: 12.21

A closely related ratio is called PB Ratio. As of today, Heartware International,'s share price is €1.71. Heartware International,'s Book Value per Sharefor the quarter that ended in Jun. 2016 was €0.26. Hence, Heartware International,'s P/B Ratio of today is 6.50.


Heartware International, Price-to-Tangible-Book Historical Data

The historical data trend for Heartware International,'s Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International, Price-to-Tangible-Book Chart

Heartware International, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Heartware International, Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Heartware International,'s Price-to-Tangible-Book

For the Medical Devices subindustry, Heartware International,'s Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heartware International,'s Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heartware International,'s Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Heartware International,'s Price-to-Tangible-Book falls into.



Heartware International, Price-to-Tangible-Book Calculation

Heartware International,'s price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2016 )
=1.71/0.131
=13.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Heartware International, Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Heartware International,'s Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartware International, (FRA:HIY1) Business Description

Traded in Other Exchanges
N/A
Address
Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Heartware International, (FRA:HIY1) Headlines

No Headlines